The Division of Medical Oncology faculty are dedicated to the creation of a cancer-free world through our efforts in research, clinical care, education, and philanthropy. Faculty research is conducted as an integrated effort within The Ohio State University Comprehensive Cancer Center, one of 40 such centers in the United States designated by the National Cancer Institute. Our research spans the spectrum of basic laboratory science, clinical investigation, and population science.
The Division of Medical Oncology program takes particular pride in our commitment to translational research investigations that involve both clinical and basic scientists in directly transforming their to our patients through interdisciplinary disease centers, each directed by nationally recognized leaders whom are responsible for orchestrating the clinical care and research.
Our established disease centers include those focusing upon breast cancer, gastrointestinal cancers, genitourinary cancers, sarcomas, lung cancers, head and neck cancers and endocrine cancers. Our efforts are enhanced by National Cancer Institute support for Phase I and Phase II clinical trials, allowing us to bring the latest in novel therapies to patients at the Arthur G. James Cancer Hospital and Solove Research Institute. Access to new trials is further enhanced through our membership in the cooperative group, Cancer and Leukemia Group B (CALGB), a national network of 26 university medical centers that collaborate on large scale clinical studies.
Our reputation for excellence in cancer research serves as a magnet for recruitment of the best young investigators to our faculty, fellows in training, and outstanding nursing staff to serve our patients with exceptional medical care at the Arthur G. James Cancer Hospital and Solove Research Institute. Although our faculty and staff are distinguished by their commitment to research while providing our patients with access to the latest treatment advances, our team is equally committed to excellence in compassionate cancer care.
The OSUCCC – James has hundreds of open clinical trials at any given time, with some of the world’s latest discoveries available to clinical trial patients right here in Columbus, Ohio. In fact, patients have access to more cancer clinical trials here than at nearly any other hospital in the region, as well as access to some of the most advanced, targeted treatments and drugs available.
The OSUCCC – James is one of only a few U.S. cancer centers funded by the National Cancer Institute (NCI) to conduct phase I and phase II clinical trials on novel anti-cancer drugs. These trials go only to centers that demonstrate an exemplary capacity for research and clinical care, as well as the expertise to deliver the latest in treatments, and the infrastructure to interpret and track treatment results.